In the BioHarmony Drug Report Database

"Preview" Icon

Eluxadoline

Viberzi (eluxadoline) is a small molecule pharmaceutical. Eluxadoline was first approved as Viberzi on 2015-05-27. It is used to treat irritable bowel syndrome in the USA. It is known to target mu-type opioid receptor and delta-type opioid receptor. Viberzi’s patents are valid until 2033-03-14 (FDA).

 

Trade Name

 

Viberzi
 

Common Name

 

eluxadoline
 

ChEMBL ID

 

CHEMBL2159122
 

Indication

 

irritable bowel syndrome
 

Drug Class

 

Analgesics (mixed opiate receptor agonists/antagonists)

Image (chem structure or protein)

Eluxadoline structure rendering